Research and development
05.10.2017, 08:33
Microbes in permafrost are major contributors to climate change, research shows.
04.10.2017, 08:17
New research says volcanic eruptions can contribute to El Niño weather events, a finding that could lead to better predictions for coming seasons.
04.10.2017, 08:15
Chronic bronchitis is a precursor to the deadly and incurable COPD, but there is no test to diagnose the disease. New research could change that.
04.10.2017, 07:16
A new analysis suggests that open-ocean aquaculture for three species of finfish is a viable option for industry expansion under most climate change scenarios – an option that may provide a new source of protein for the world’s growing population
03.10.2017, 13:36
MIT alumnus and two others honored for discovering the molecular mechanisms of circadian rhythms.
03.10.2017, 13:33
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
03.10.2017, 13:28
Recently discovered phenomenon could provide a way to bypass the limits to Moore’s Law.
03.10.2017, 10:38
Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams
03.10.2017, 08:00
Creating a process called endocytosis on demand could lead to new ways to deliver drugs directly to cells.
02.10.2017, 09:32
Alcon introduces new innovations in cataract surgery at European Society of Cataract & Refractive Surgeons 2017 annual congress
02.10.2017, 08:38
Mantis shrimp have mushroom bodies in their brains. Here's why that's even weirder than it sounds.
02.10.2017, 08:36
A new laser-based way to quickly and accurately detect explosives, even from remote locations, could one day be used at airports and on the battlefield.
29.09.2017, 17:10
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a rights offering to existing holders of its common stock
29.09.2017, 14:00
Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced financial results for the half-year ended June 30, 2017
28.09.2017, 09:53
Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets
Комментарии